(Q34291192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

Choices of therapy for exercise-induced asthma in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Price JF

series ordinal

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

56 Suppl 66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

12-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11421936%20AND%20SRC:MED&resulttype=core&format=json

Asthma knowledge, attitudes, and quality of life in adolescents

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

What do school teachers know about asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Standardization of exercise tests in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Validation of an asthma symptom diary for interventional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Measuring quality of life in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Inhibition of exercise-induced asthma by different pharmacological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Prevention of exercise induced asthma by inhaled salmeterol xinafoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Effect of inhaled disodium cromoglycate and albuterol on energy cost of running in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Persistent increase in plasma and urinary leukotrienes after acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Clinical effect of Diskus ™ dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

Clinical and immunological characteristics of pre-school asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Inhibition of exercise-induced asthma by theophylline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

The effect of age on bronchodilator responsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Effect of disodium cromoglycate on ventilation and gas exchange during exercise in asthmatic children with a postexertion FEV1 fall less than 15 percent

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Urinary leukotriene E after exercise challenge in children with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00003.X

7 January 2021